How much do paid clinical trials in Amarillo pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Amarillo?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Amarillo safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Amarillo typically complete one or two studies per year.

Paid Clinical Trials Amarillo, TX — 94 Studies Recruiting (Jul 2026)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought

Panhandle Eye Group LLP Southwest Retina Specialists — Amarillo, Texas (1.6 mi) · Sponsor: Genentech, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT04853251)

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Atherosclerotic Cardiovascular Disease (ASCVD) Phase 3 Interventional 340 participants sought

PharmaTex Research LLC — Amarillo, Texas (1.6 mi) · Sponsor: Novartis Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT06813911)

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Polymyositis, Dermatomyositis Phase 3 Interventional 240 participants sought

Research Site — Amarillo, Texas (1.6 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06455449)

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

Recurrent or Metastatic Solid Tumors Phase 2 Interventional 520 participants sought

Texas Oncology - West Texas — Amarillo, Texas (1.6 mi) · Sponsor: Daiichi Sankyo

See eligibility & contact on ClinicalTrials.gov (NCT06330064)

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus Phase 2 Interventional 405 participants sought

Amarillo Center for Clinical Research — Amarillo, Texas (1.6 mi) · Sponsor: Boehringer Ingelheim

See eligibility & contact on ClinicalTrials.gov (NCT07409181)

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Obesity, Overweight Phase 1 Interventional 114 participants sought

Amarillo Medical Specialists — Amarillo, Texas (1.6 mi) · Sponsor: Novo Nordisk A/S

See eligibility & contact on ClinicalTrials.gov (NCT07607587)

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma Phase 3 Interventional 62 participants sought

Texas Tech University Health Sciences Center-Amarillo — Amarillo, Texas (1.6 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT05235165)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought

The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05896189)

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO) Phase 2 Interventional 160 participants sought

Amarillo, Texas — Amarillo, Texas (1.6 mi) · Sponsor: EyeBiotech Ltd.

See eligibility & contact on ClinicalTrials.gov (NCT07205887)

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis, MASH With Fibrosis Phase 3 Interventional 1,650 participants sought

Akero Clinical Study Site — Amarillo, Texas (1.6 mi) · Sponsor: Akero Therapeutics, Inc

See eligibility & contact on ClinicalTrials.gov (NCT06215716)

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Acute Coronary Syndrome Phase 3 Interventional 2,000 participants sought

Research Site — Amarillo, Texas (1.6 mi) · Sponsor: DalCor Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT05918861)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought

Texas Tech University Health Sciences Center-Amarillo — Amarillo, Texas (1.6 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT04322318)

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Breast Cancer, Gastric Cancer Phase 2 Interventional 200 participants sought

Texas Oncology - West Texas — Amarillo, Texas (1.6 mi) · Sponsor: Jazz Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT06695845)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought

The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04267848)

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Breast Cancer N/A Observational 30,000 participants sought

Harrington Cancer Center — Amarillo, Texas (1.6 mi) · Sponsor: Agendia

See eligibility & contact on ClinicalTrials.gov (NCT03053193)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought

The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT03851445)

BOOM-IBD2 Pivotal Clinical Trial

Ulcerative Colitis, Inflammatory Bowel Diseases N/A Interventional 137 participants sought

Amarillo Premier Research (Objective Health) — Amarillo, Texas (1.6 mi) · Sponsor: Boomerang Medical

See eligibility & contact on ClinicalTrials.gov (NCT06571669)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,000 participants sought

The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05334069)

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Focal Segmental Glomerulosclerosis Phase 3 Interventional 286 participants sought

Texas Tech University Health Sciences Center-Amarillo-63885 — Amarillo, Texas (1.6 mi) · Sponsor: Boehringer Ingelheim

See eligibility & contact on ClinicalTrials.gov (NCT07220083)

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic Phase 3 Interventional 600 participants sought

Amarillo Center for Clinical Research — Amarillo, Texas (1.6 mi) · Sponsor: Janssen Research & Development, LLC

See eligibility & contact on ClinicalTrials.gov (NCT07438496)

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Limited Stage Small Cell Lung Cancer Phase 2 Interventional 250 participants sought

Texas Oncology - West Texas — Amarillo, Texas (1.6 mi) · Sponsor: SCRI Development Innovations, LLC

See eligibility & contact on ClinicalTrials.gov (NCT06773910)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought

Ohio State University Telemedicine — Amarillo, Texas (1.6 mi) · Sponsor: Sameek Roychowdhury

See eligibility & contact on ClinicalTrials.gov (NCT06906562)

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Obesity Phase 3 Interventional 1,150 participants sought

Amarillo Medical Specialists — Amarillo, Texas (1.6 mi) · Sponsor: Novo Nordisk A/S

See eligibility & contact on ClinicalTrials.gov (NCT07339423)

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC) Phase 3 Interventional 1,040 participants sought

The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06661720)

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Heart Failure Phase 3 Interventional 4,200 participants sought

Pharmatex Research — Amarillo, Texas (1.6 mi) · Sponsor: Boehringer Ingelheim

See eligibility & contact on ClinicalTrials.gov (NCT06935370)

Paid Clinical Trials in Amarillo, TX

Studies recruiting near Amarillo right now